Role of the Phospholipase C Pathway and Calcium Mobilization in Oxytocin-Induced Contraction of Lacrimal Gland Myoepithelial Cells.
Actins
/ metabolism
Animals
Blotting, Western
Calcium
/ metabolism
Cells, Cultured
Electrophoresis, Polyacrylamide Gel
Epithelial Cells
/ metabolism
Lacrimal Apparatus
/ diagnostic imaging
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Microscopy, Fluorescence, Multiphoton
Muscle Contraction
/ physiology
Muscle, Smooth
/ metabolism
Oxytocics
/ pharmacology
Oxytocin
/ pharmacology
Real-Time Polymerase Chain Reaction
Tears
/ physiology
Type C Phospholipases
/ physiology
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
entrez:
23
11
2021
pubmed:
24
11
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
We reported that oxytocin (OXT), added to freshly prepared lacrimal gland lobules, induced myoepithelial cell (MEC) contraction. In other systems, OXT activates phospholipase C (PLC) generating Inositol 1,4,5-trisphosphate (IP3) which increases intracellular calcium concentration ([Ca2+]i) causing contraction. The aim of the current study was to investigate the role of this pathway in OXT-induced contraction of MEC. Tear volume was measured using the cotton thread method. Lacrimal gland MEC were isolated and propagated from α-smooth muscle actin (SMA)-green fluorescent protein (GFP) mice, in which MEC express GFP making them easily identifiable. RNA and protein samples were prepared for RT-PCR and Western blotting for G protein expression. Changes in [Ca2+]i were measured in Fura-2 loaded MEC using a ratio imaging system. MEC contraction was monitored in real time and changes in cell size were quantified using ImageJ software. OXT applied either topically to surgically exposed lacrimal glands or delivered subcutaneously resulted in increased tear volume. OXT stimulated lacrimal gland MEC contraction in a dose-dependent manner, with a maximum response at 10-7 M. MEC express the PLC coupling G proteins, Gαq and Gα11, and their activation by OXT resulted in a concentration-dependent increase in [Ca2+]i with a maximum response at 10-6 M. Furthermore, the activation of the IP3 receptor to increase [Ca2+]i is crucial for OXT-induced MEC contraction since blocking the IP3 receptor with 2-APB completely abrogated this response. We conclude that OXT uses the PLC/Ca2+ pathway to stimulate MEC contraction and increase lacrimal gland secretion.
Identifiants
pubmed: 34812841
pii: 2778100
doi: 10.1167/iovs.62.14.25
pmc: PMC8626846
doi:
Substances chimiques
Actins
0
Oxytocics
0
alpha-smooth muscle actin, mouse
0
Oxytocin
50-56-6
Type C Phospholipases
EC 3.1.4.-
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
25Subventions
Organisme : NEI NIH HHS
ID : R01 EY019470
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029602
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029870
Pays : United States
Références
Pflugers Arch. 2001 Apr;442(1):57-63
pubmed: 11374069
FEBS Lett. 1993 Jun 14;324(2):241-5
pubmed: 8508928
Curr Mol Med. 2004 May;4(3):291-301
pubmed: 15101686
Physiol Rev. 2001 Apr;81(2):629-83
pubmed: 11274341
Am J Med Sci. 1988 Nov;296(5):303-7
pubmed: 3195625
FASEB J. 2002 Aug;16(10):1145-50
pubmed: 12153982
Front Immunol. 2020 Aug 12;11:1713
pubmed: 32903439
Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9503-15
pubmed: 22039237
Exp Eye Res. 2007 May;84(5):894-904
pubmed: 17362931
Mol Hum Reprod. 1998 Jun;4(6):527-32
pubmed: 9665335
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11699-704
pubmed: 8876199
Peptides. 1997;18(9):1377-81
pubmed: 9392839
J Biol Chem. 2012 Feb 3;287(6):3617-29
pubmed: 22069312
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26822-26832
pubmed: 33033227
Naunyn Schmiedebergs Arch Pharmacol. 2002 May;365(5):399-405
pubmed: 12012026
Oncogene. 2003 Sep 4;22(38):6054-60
pubmed: 12955084
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5827-32
pubmed: 25902527
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16096-101
pubmed: 16249339
Cell Calcium. 2003 Jul;34(1):97-108
pubmed: 12767897
Stem Cells. 2006 Jan;24(1):13-22
pubmed: 16099999
Curr Mol Biol Rep. 2015 Sep 1;1(3):115-123
pubmed: 26688786
Eur J Pharmacol. 1992 Jun 5;216(2):311-3
pubmed: 1397015
Fed Proc. 1984 Jan;43(1):80-6
pubmed: 6690341
Mol Endocrinol. 2007 Mar;21(3):740-52
pubmed: 17170070
FASEB J. 2019 Feb;33(2):2199-2211
pubmed: 30226811
Prog Retin Eye Res. 2009 May;28(3):155-77
pubmed: 19376264
Cell Tissue Res. 1997 Sep;289(3):473-85
pubmed: 9232826
J Biochem. 1997 Sep;122(3):498-505
pubmed: 9348075
Am J Pathol. 2020 Oct;190(10):2067-2079
pubmed: 32679229
Biol Cell. 1996;86(2-3):175-81
pubmed: 8893507
Am J Physiol. 1997 May;272(5 Pt 1):E870-6
pubmed: 9176188
Physiol Behav. 1996 Nov;60(5):1311-5
pubmed: 8916187
J Biol Chem. 1991 Sep 25;266(27):18206-16
pubmed: 1655741
Sci Rep. 2018 Jul 2;8(1):9919
pubmed: 29967327
Bone. 2008 Sep;43(3):501-10
pubmed: 18571490
Nature. 1993 Jan 28;361(6410):315-25
pubmed: 8381210
ScientificWorldJournal. 2012;2012:252034
pubmed: 22919300
Biol Reprod. 2011 Jul;85(1):13-21
pubmed: 21368298
Am J Anat. 1971 Oct;132(2):133-45
pubmed: 5112466
Endocrinology. 1995 Apr;136(4):1509-15
pubmed: 7895660
Invest Ophthalmol Vis Sci. 1997 May;38(6):1261-70
pubmed: 9152245
EMBO J. 2011 May 18;30(10):1896-906
pubmed: 21487391
Histol Histopathol. 1995 Oct;10(4):821-7
pubmed: 8574002
Oncogene. 2020 Sep;39(37):5917-5932
pubmed: 32782397
J Neurochem. 2010 Sep 1;114(5):1424-35
pubmed: 20557424
Exp Physiol. 2001 Mar;86(2):223-37
pubmed: 11429639
Sci Rep. 2018 Oct 26;8(1):15880
pubmed: 30367106